Your browser doesn't support javascript.
loading
Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC.
Jackson, Andrew; Hua, Chia-Ho; Olch, Arthur; Yorke, Ellen D; Rancati, Tiziana; Milano, Michael T; Constine, Louis S; Marks, Lawrence B; Bentzen, Soren M.
Afiliación
  • Jackson A; Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York. Electronic address: jacksona@mskcc.org.
  • Hua CH; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Olch A; Radiation Oncology Department, University of Southern California and Children's Hospital, Los Angeles, California.
  • Yorke ED; Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Milano MT; Department of Radiation Oncology, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, New York.
  • Constine LS; Department of Radiation Oncology, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, New York; Pediatrics, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, New York.
  • Marks LB; Department of Radiation Oncology and Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Bentzen SM; Department of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland.
Int J Radiat Oncol Biol Phys ; 119(2): 697-707, 2024 Jun 01.
Article en En | MEDLINE | ID: mdl-38760117
ABSTRACT
The major aim of Pediatric Normal Tissue Effects in the Clinic (PENTEC) was to synthesize quantitative published dose/-volume/toxicity data in pediatric radiation therapy. Such systematic reviews are often challenging because of the lack of standardization and difficulty of reporting outcomes, clinical factors, and treatment details in journal articles. This has clinical consequences optimization of treatment plans must balance between the risks of toxicity and local failure; counseling patients and their parents requires knowledge of the excess risks encountered after a specific treatment. Studies addressing outcomes after pediatric radiation therapy are particularly challenging because (a) survivors may live for decades after treatment, and the latency time to toxicity can be very long; (b) children's maturation can be affected by radiation, depending on the developmental status of the organs involved at time of treatment; and (c) treatment regimens frequently involve chemotherapies, possibly modifying and adding to the toxicity of radiation. Here we discuss basic reporting strategies to account for the actuarial nature of the complications; the reporting of modeling of abnormal development; and the need for standardized, comprehensively reported data sets and multivariate models (ie, accounting for the simultaneous effects of radiation dose, age, developmental status at time of treatment, and chemotherapy dose). We encourage the use of tools that facilitate comprehensive reporting, for example, electronic supplements for journal articles. Finally, we stress the need for clinicians to be able to trust artificial intelligence models of outcome of radiation therapy, which requires transparency, rigor, reproducibility, and comprehensive reporting. Adopting the reporting methods discussed here and in the individual PENTEC articles will increase the clinical and scientific usefulness of individual reports and associated pooled analyses.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Traumatismos por Radiación / Neoplasias Límite: Child / Child, preschool / Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Traumatismos por Radiación / Neoplasias Límite: Child / Child, preschool / Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2024 Tipo del documento: Article